Detalhe da pesquisa
1.
Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.
Ann Surg Oncol;
31(1): 356-364, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37838650
2.
Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?
Ann Surg Oncol;
29(11): 6660-6668, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35616744
3.
ASO Visual Abstract: Surgical Decision Making in Genetically High-Risk Women-Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy.
Ann Surg Oncol;
31(2): 1018-1019, 2024 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38017128
4.
ASO Visual Abstract: Incidence of Occult Breast Cancer in Carriers of BRCA1/2 and Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy-When is Sentinel Lymph Node Biopsy Indicated?
Ann Surg Oncol;
29(11): 6671-6672, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35802212
5.
Counselling Framework for Germline BRCA1/2 and PALB2 Carriers Considering Risk-Reducing Mastectomy.
Curr Oncol;
31(1): 350-365, 2024 Jan 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38248108
6.
Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy.
Eur J Surg Oncol;
50(6): 108324, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38636249